Global Sickle Cell Treatment market is segmented by Treatment Modality (Bone Marrow Transplant, Blood Transfusion, and Pharmacotherapy), End User (Hospitals, Specialty Clinics, and Others),Regional Forecasts 2021-2027

BIZ4639379
200 Pages
September 2021
Pharmaceuticals

Download Sample Get Discount

Global Sickle Cell treatment Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2021-2027. Sickle cell disease is a category of diseases that impair hemoglobin, the molecule that transports oxygenated blood. A deformed red blood cell with the shape of a sickle or crescent is found in people with this disease. Symptoms of sickle cell disease generally begin in early childhood and continue throughout adolescence. Red blood cells break down prematurely as they alter form, which can cause anaemia. The aim of sickle cell anaemia treatment is to reduce discomfort, relieve pain, and prevent complications. Some adolescents and teens are treated with medications and blood transfusions. The market is driven by the increasing research and development activity and increasing prevalence of sickle cell disease. For instance, as per the National Health Institute, over 90% of the world's SCD population resides in three countries: Nigeria, India, and the Democratic Republic of Congo, where the disease affects up to 2% of the population and the carrier prevalence rate (sickle cell trait) is as high as 10% to 30%. However, high cost of treatments may impede market growth over the forecast period of 2021-2027.

Geographically, the sickle cell treatment market in North America is dominated by the United States, which is the market's biggest contributor. Improved access to SCD treatment and potential pipeline medicines are attributed with the region's growth. The substantial government support in the United States will help promote the market's healthy growth.

Major market player included in this report are:

Bristol Myers Squibb Co.

Global Blood Therapeutics Inc.

Bluebird Biotechnology

F.Hoffmann-La Roche

Emmaus Medical Inc.

Eli-Lilly and Co.

Baxter Inc.

Medunik USA.Inc.

Addmedica Inc.

Glycomimetics Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Modality:

Blood Transfusion

Bone Marrow Transplant

Pharmacotherapy

By End user:

Hospitals

Specialty Clinics

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027.

Target Audience of the Global Sickle Cell treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Sickle Cell treatment Market, by Region, 2019-2027 (USD Billion)

1.2.2. Sickle Cell treatment Market, by Treatment Modality, 2019-2027 (USD Billion)

1.2.3. Sickle Cell treatment Market, by End user, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Sickle Cell treatment Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Sickle Cell treatment Market Dynamics

3.1. Sickle Cell treatment Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing research and development activity

3.1.1.2. Increasing prevalence of sickle cell disease

3.1.2. Market Restraint

3.1.2.1. High cost of treatments

3.1.3. Market Opportunities

3.1.3.1. Widespread population of African descent

Chapter 4. Global Sickle Cell treatment Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Sickle Cell treatment Market, by Treatment Modality

5.1. Market Snapshot

5.2. Global Sickle Cell treatment Market by Treatment Modality, Performance - Potential Analysis

5.3. Global Sickle Cell treatment Market Estimates & Forecasts by Treatment modality 2018-2027 (USD Billion)

5.4. Sickle Cell treatment Market , Sub Segment Analysis

5.4.1. Blood Transfusion

5.4.2. Bone Marrow Transplant

5.4.3. Pharmacotherapy

Chapter 6. Global Sickle Cell treatment Market, by End user

6.1. Market Snapshot

6.2. Global Sickle Cell treatment Market by End User, Performance - Potential Analysis

6.3. Global Sickle Cell treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)

6.4. Sickle Cell treatment Market , Sub Segment Analysis

6.4.1. Hospitals

6.4.2. Specialty Clinics

6.4.3. Others

Chapter 7. Global Sickle Cell treatment Market, Regional Analysis

7.1. Sickle Cell treatment Market , Regional Market Snapshot

7.2. North America Sickle Cell treatment Market

7.2.1. U.S. Sickle Cell treatment Market

7.2.1.1. Treatment modality breakdown estimates & forecasts, 2018-2027

7.2.1.2. End user breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Sickle Cell treatment Market

7.3. Europe Sickle Cell treatment Market Snapshot

7.3.1. U.K. Sickle Cell treatment Market

7.3.2. Germany Sickle Cell treatment Market

7.3.3. France Sickle Cell treatment Market

7.3.4. Spain Sickle Cell treatment Market

7.3.5. Italy Sickle Cell treatment Market

7.3.6. Rest of Europe Sickle Cell treatment Market

7.4. Asia-Pacific Sickle Cell treatment Market Snapshot

7.4.1. China Sickle Cell treatment Market

7.4.2. India Sickle Cell treatment Market

7.4.3. Japan Sickle Cell treatment Market

7.4.4. Australia Sickle Cell treatment Market

7.4.5. South Korea Sickle Cell treatment Market

7.4.6. Rest of Asia Pacific Sickle Cell treatment Market

7.5. Latin America Sickle Cell treatment Market Snapshot

7.5.1. Brazil Sickle Cell treatment Market

7.5.2. Mexico Sickle Cell treatment Market

7.6. Rest of The World Sickle Cell treatment Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Bristol Myers Squibb Co.

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Global Blood Therapeutics Inc.

8.2.3. Bluebird Biotechnology

8.2.4. F.Hoffmann-La Roche

8.2.5. Emmaus Medical Inc.

8.2.6. Eli-Lilly and Co.

8.2.7. Baxter Inc.

8.2.8. Medunik USA.Inc.

8.2.9. Addmedica Inc.

8.2.10. Glycomimetics Inc

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Sickle Cell treatment Market, report scope

TABLE 2. Global Sickle Cell treatment Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Sickle Cell treatment Market estimates & forecasts by Treatment Modality 2018-2027 (USD Billion)

TABLE 4. Global Sickle Cell treatment Market estimates & forecasts by End User 2018-2027 (USD Billion)

TABLE 5. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. U.S. Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. U.S. Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. U.S. Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Canada Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Canada Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Canada Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. UK Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. UK Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. UK Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. Germany Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. Germany Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. Germany Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. France Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. France Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. France Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Spain Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Spain Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Spain Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Italy Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. Italy Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Italy Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. ROE Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. ROE Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. ROE Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. China Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. China Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. China Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. India Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. India Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. India Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Japan Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Japan Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Japan Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Australia Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 55. Australia Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Australia Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. South Korea Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 58. South Korea Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. South KoreaSickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 60. ROPAC Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 61. ROPAC Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. ROPAC Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 63. Brazil Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 64. Brazil Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. Brazil Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 66. Mexico Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 67. Mexico Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. Mexico Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 69. ROLA Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 70. ROLA Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. ROLA Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 72. ROW Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 73. ROW Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. ROW Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 75. List of secondary sources used in the study of Global Sickle Cell treatment Market.

TABLE 76. List of primary sources used in the study of Global Sickle Cell treatment Market.

TABLE 77. Years considered for the study.

TABLE 78. Exchange rates considered.

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Sickle Cell Treatment market is segmented by Treatment Modality (Bone Marrow Transplant, Blood Transfusion, and Pharmacotherapy), End User (Hospitals, Specialty Clinics, and Others),Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara